Viewing StudyNCT00754494



Ignite Creation Date: 2024-05-05 @ 7:51 PM
Last Modification Date: 2024-10-26 @ 9:55 AM
Study NCT ID: NCT00754494
Status: COMPLETED
Last Update Posted: 2015-01-06
First Post: 2008-09-17

Brief Title: Erlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or Adenoma
Sponsor: National Cancer Institute NCI
Organization: National Cancer Institute NCI

Conditions & Keywords Data

Conditions:
Name
Stage IIIC Rectal Cancer
Adenomatous Polyp
Recurrent Colon Cancer
Recurrent Rectal Cancer
Stage I Colon Cancer
Stage I Rectal Cancer
Stage IIA Colon Cancer
Stage IIA Rectal Cancer
Stage IIB Colon Cancer
Stage IIB Rectal Cancer
Stage IIC Colon Cancer
Stage IIC Rectal Cancer
Stage IIIA Colon Cancer
Stage IIIA Rectal Cancer
Stage IIIB Colon Cancer
Stage IIIB Rectal Cancer
Stage IIIC Colon Cancer
Keywords: